drugset / Trial / NCT01848470
Multiple Ascending Doses Study of CG400549
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to investigate the safety and tolerability of 3 multiple and escalating dose regimens of CG400549 administered orally in healthy volunteers.
Timeline
- Start
- 2010-05
- Primary completion
- 2011-03
- Completion
- 2011-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CG400549 | Small molecule | 320 mg | Oral |
| Subject | CG400549 | Small molecule | 640 mg | Oral |
| Subject | CG400549 | Small molecule | 960 mg | Oral |
Indications
No indication recorded.